Upon closer examination, it is apparent that AIBiotech has provided access to a number of genes on the ACMG’s recommended incidental findings report: AIBiotech has provided exome sequencing of MYH7, MYBPC3, and TNNT2 (three of the genes related to HCM risks) and testing of SCN5A (a gene on the ACMG’s list of recommended reporting for LQTS and related acquired arrhythmias). Here, MYH7 is linked to familial long QT syndrome.